Advertisement

Reactions Weekly

, Volume 1713, Issue 1, pp 81–81 | Cite as

Carboplatin/gefitinib/paclitaxel

Loss of appetite and peripheral nerve damage: case report
Case report

Reference

  1. Hirabae A, et al. Concurrent administration of an epidermal growth factor receptor tyrosine kinase inhibitor and cytotoxic anticancer drug to treat epidermal growth factor receptor gene mutation-positive and mutation-negative lung cancers. [Japanese]. Haigan / Japanese Journal of Lung Cancer 58: 127-131, No. 2, 2018. Available from: URL: http://doi.org/10.2482/haigan.58.127 [Japanese; summarised from a translation] - JapanCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations